Skip to main content
Clinical Trials/CTRI/2012/04/002553
CTRI/2012/04/002553
Completed
未知

Randomized Controlled Trial Comparing Two Different Regimes of Magnesium Sulphate in Severe Pre-eclampsia: A Pilot Study - PIPES Trial

JIPMER0 sites402 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: O141- Severe pre-eclampsiaHealth Condition 2: null- Women with Severe Pre-eclampsia
Sponsor
JIPMER
Enrollment
402
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
March 31, 2013
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
JIPMER

Eligibility Criteria

Inclusion Criteria

  • Any pregnant woman with Severe Pre\- eclampsia as per the ACOG Criteria:
  • oSystolic blood pressure of 160 mm Hg or higher or diastolic blood pressure of 110 mm Hg or higher on two occasions at least 6 hours apart.
  • oProteinuria of 5 gm or higher in a 24\-hour urine specimen or 3\+ or greater on two random urine samples collected at least 4 hours apart.
  • oOliguria of less than 500 ml in 24 hours.
  • oCerebral or visual disturbances
  • oPulmonary edema or cyanosis
  • oEpigastric or right upper\-quadrant pain
  • oImpaired liver function
  • oThrombocytopenia
  • oFetal growth restriction

Exclusion Criteria

  • oMultiple Pregnancy
  • oPlatelet count \< 50,000/mm3
  • oPlasma creatinine value \>\= 2mg/dl
  • oComatose patients
  • oDeranged coagulation profile
  • oKnown case of myasthenia gravis
  • oKnown case of seizure disorder
  • oPatients with Eclampsia (defined as presence of new\-onset grand mal seizures in a woman with preeclampsia).
  • oHypersensitivity to Magnesium.
  • oWomen who have received have received magnesium sulphate therapy before being referred.

Outcomes

Primary Outcomes

Not specified

Similar Trials